Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 4 A SPEC. ISSUE, 1997, Pages 528-530

  Farré, Magí ^a   Roset, Pere N ^a   Badenas, Josep M ^a   Ugena, Balbina ^a   Márquez, Miguel ^b   Albet, Carlos ^b   Herrero, Eduardo ^b   Ortiz, José A ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

Author keywords

CAS 100981 43 9; Ebrotidine; FI 3542, clinical pharmacokinetics, phase I study, tolerability; H2 Receptor antagonist

Indexed keywords

EBROTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST;

ADULT; ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FLATULENCE; GASTRODUODENAL ULCER; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; BENZENESULFONATES; HALF-LIFE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; THIAZOLES;

EID: 0030958005     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Anglada, L., Márquez, M., Sacristán, A. et al., Eur. J. Med. Chem. 23, 97 (1988)
2. Konturek, S. J., Brzozowski, T., Drodzdowicz, D. et al., Eur. J. Gastroenterol. Hepatol. 3, 941 (1991)
3. Brzozowski, T., Majka, J., Konturek, S. J., Digestion 51, 27 (1992)
4. Slomiany, B. L., Piotrowski, J., Mojtahed, H. et al., Gen. Pharmacol. 2, 203 (1992)
5. Romero, A., Gómez, F., Villamayor, F. et al., Cell. Prolif. 28, 393 (1995)
6. Patel, S. S., Wilde, M. I., Drugs 51, 974 (1996)
7. Gabryelewicz, A., Konturek, S. J., Butruk, E. et al., Eur. J. Gastroenterol. Hepatol. 7, 361 (1995)
8. Herrero, E., Matov, V., Krastev, Z. et al., Methods Find. Exp. Clin. Pharmacol. 17, Abs. A-139 (1995)
9. Albet, C., Pérez, J. A., Marquez, M. et al., Methods Find. Exp. Clin. Pharmaeol. 16 (Suppl 1), 124 (1994)
10. Castelló, J. M., Sacristán, A., Ortiz, J. A., Drugs Today 21, 135 (1996)
11. Brunton, L. L., in: The pharmacological basis of therapeutics, J. G. Hardman, L. E. Limbird, P. B. Molinoff et al. (eds.), pp. 901-915, McGraw-Hill, New York (1996)
12. Muñoz-Navas, M., Taxonera, C., Val, J. et al., Hell. J. Gastroenterol. 5, Abs. 943 (1992)